NCHR urges FDA to require more diversity in trials to improve accuracy of pulse ox devices

December 2, 2022: NCHR testified at an FDA meeting that there is strong evidence that commonly-used pulse oximeters are less reliable for patients with pigmented skin. The FDA’s current guidelines do not require product labeling to address the impact of skin pigmentation on pulse oximetry. While labeling is important to alert users to possible inaccuracies, it does not diminish the importance of developing devices that are effective for everyone.

Read More »

FDA Warns Against Dental Amalgam Fillings for Children and Many Adults

Since the 1990s, patients with amalgam fillings have reported health problems that they believe are caused by their exposure to mercury. The amalgam is known to release small amounts of mercury over time, and while low levels of mercury vapor is not known to be harmful for most people, the long-term health risks of mercury inhalation are not clear.

Read More »